×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Events
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Cure Connections

Following a discussion on where to find reliable information on chronic lymphocytic leukemia (CLL) and treatment, participants share their closing thoughts.
Participants highlight the importance of proper support and communication while receiving therapy for chronic lymphocytic leukemia (CLL).
 
Considerations for what happens when a patient progresses with chronic lymphocytic leukemia (CLL).
 
Shared insight on the long-term nature of treatment for chronic lymphocytic leukemia (CLL).
 
More

Cure Expert Connections

Perspectives on treatment decision-making in cutaneous squamous cell carcinoma, particularly regarding who is involved in selecting therapy.
Dr. Todd Schlesinger shares his experience with cemiplimab, an immunotherapy agent used to treat cutaneous squamous cell carcinoma.
 
Considerations for the use of immunotherapy, a novel approach to treatment, in patients with cutaneous squamous cell carcinoma.
 
A comprehensive review of both surgical and systemic treatment options for cutaneous squamous cell carcinoma.
More

Cure TV

Nalie Agustin
“Often you think we’re the victim, but there’s a lot that you can do to be your own advocate and participate in your healing,” says stage four metastatic breast cancer thriver Nalie Agustin.
 
Dr. Sara Hurvitz
Expert Dr. Sara Hurvitz discusses why cancer survivors should discuss their risk factors during the COVID-19 pandemic with their healthcare providers.
Elisa Krill-Jackson, MD
Genetic testing offers a care team a wealth of knowledge to help them craft treatments, but it also can help match patients to clinical trials for potentially better outcomes.
Patrick I. Borgen, MD
In the face of the COVID-19 pandemic patients with cancer who are considered to have weakened immune systems need to have a special emphasis placed on their care.
 
More

Cure Speaking Out

Kristie L. Kahl and Cindy Borassi
Cindy Borassi, executive director of the Colon Cancer Foundation, talked about the organization’s upcoming Early-Age Onset Colorectal Cancer Summit.
 
Kristie L. Kahl and Susan K. Peterson
Dr. Susan K. Peterson, a co-director of the CCF’s annual EAOCRC Summit, discussed issues that occur during survivorship among young adults diagnosed with colorectal cancer.
 
Kristie L. Kahl and Zsofia Stadler
Dr. Zsofia Stadler, a co-director of the CCF’s annual EAOCRC Summit, discussed hereditary risks for colorectal cancer, and how primary care physicians play a role in documenting family history.
 
Kristie L. Kahl and Zsofia Stadler
Dr. Zsofia Stadler, a co-director of the CCF’s annual EAOCRC Summit, discussed the rise in early-age onset colorectal cancer, and what signs and symptoms young adults should look out for.
 
More
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×